QUINOLONE BINDING TO DNA IS MEDIATED BY MAGNESIUM-IONS

被引:172
作者
PALU, G
VALISENA, S
CIARROCCHI, G
GATTO, B
PALUMBO, M
机构
[1] UNIV PADUA, DEPT PHARMACEUT SCI, VIA MARZOLO, I-35131 PADUA, ITALY
[2] CNR, IST GENET BIOCHIM & EVOLUZ, PAVIA, ITALY
[3] UNIV PADUA, SCH MED, INST MICROBIOL, I-35100 PADUA, ITALY
关键词
NORFLOXACIN; PLASMID DNA; TERNARY COMPLEX;
D O I
10.1073/pnas.89.20.9671
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The binding of plasmid DNA to norfloxacin, a quinolone antibacterial agent, was investigated by fluorescence, electrophoretic DNA unwinding, and affinity chromatography techniques. The amount of quinolone bound to DNA was modulated by the concentration of Mg2+. No interaction was evident in the absence of Mg2+ or in the presence of an excess of Mg2+, whereas maximum binding was observed at a Mg2+ concentration of 1-2 mM. The experimental data can be fitted to the formation of three types of Mg adducts: a binary adduct with norfloxacin and Mg2+, a binary adduct with DNA and Mg2+, and a ternary adduct with quinolone, plasmid, and Mg2+. We propose a model for the ternary complex, in which Mg acts as a bridge between the phosphate groups of the nucleic acid and the carbonyl and carboxyl moieties of norfloxacin. Additional stabilization may arise from stacking interactions between the condensed rings of the drug and DNA bases (especially guanine and adenine), which may account for the preference exhibited by quinolones for single-stranded and purine-rich regions of nucleic acids. Other possible biochemical pathways of drug action are suggested by the observation that norfloxacin binds Mg2+ under conditions that are close to physiological.
引用
收藏
页码:9671 / 9675
页数:5
相关论文
共 29 条
[2]   ELECTROSTATIC MECHANISM OF CHROMATIN FOLDING [J].
CLARK, DJ ;
KIMURA, T .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 211 (04) :883-896
[3]   DIAGNOSTIC USES OF HILL (LOGIT AND NERNST) PLOTS [J].
CORNISHBOWDEN, A ;
KOSHLAND, DE .
JOURNAL OF MOLECULAR BIOLOGY, 1975, 95 (02) :201-212
[4]   CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES [J].
CULLEN, ME ;
WYKE, AW ;
KURODA, R ;
FISHER, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :886-894
[5]   BIOLOGY OF BACTERIAL DEOXYRIBONUCLEIC-ACID TOPOISOMERASES [J].
DRLICA, K .
MICROBIOLOGICAL REVIEWS, 1984, 48 (04) :273-289
[6]   STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER-DNA OLIGOMER COMPLEX IN SOLUTION [J].
GAO, XL ;
MIRAU, P ;
PATEL, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 223 (01) :259-279
[7]   DNA GYRASE - ENZYME THAT INTRODUCES SUPERHELICAL TURNS INTO DNA [J].
GELLERT, M ;
MIZUUCHI, K ;
ODEA, MH ;
NASH, HA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (11) :3872-3876
[8]   NALIDIXIC-ACID RESISTANCE - 2ND GENETIC CHARACTER INVOLVED IN DNA GYRASE ACTIVITY [J].
GELLERT, M ;
MIZUUCHI, K ;
ODEA, MH ;
ITOH, T ;
TOMIZAWA, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (11) :4772-4776
[9]  
HOLLER E, 1983, BIOCHEMISTRY-US, V22, P4926
[10]   GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF NORFLOXACIN RESISTANCE IN ESCHERICHIA-COLI [J].
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
TUNG, C ;
MCHUGH, GL ;
SWARTZ, MN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :639-644